# immunotherapy_scRNAseq_papers


* 2023 Cancer Cell [Anti-PD-1 immunotherapy with androgen deprivation therapy induces robust immune infiltration in metastatic castration-sensitive prostate cancer](https://www.cell.com/cancer-cell/fulltext/S1535-6108(23)00362-8)

* 2023 Cell [Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapy](https://www.sciencedirect.com/science/article/pii/S0092867422007231)

* 2023 Nature Med [Intratumoral dendritic cell-CD4+ T helper cell niches enable CD8+ T cell differentiation following PD-1 blockade in hepatocellular carcinoma](https://pubmed.ncbi.nlm.nih.gov/37322116/)

* 2020 PNAS [Circulating immune cell phenotype dynamics reflect the strength of tumorâ€“immune cell interactions in patients during immunotherapy](https://www.pnas.org/doi/10.1073/pnas.1918937117)

* 2021 Cancer Cell [Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma](https://pubmed.ncbi.nlm.nih.gov/33711272/)

* 2021 Nature Med [A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer](https://www.nature.com/articles/s41591-021-01323-8)

* 2019 Nature Med [Clonal replacement of tumor-specific T cells following PD-1 blockade](https://www.nature.com/articles/s41591-019-0522-3)

* 2021 Cancer Cell [Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy](https://pubmed.ncbi.nlm.nih.gov/33861994/)

* 2021 Nature [Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers](https://www.nature.com/articles/s41586-021-03752-4)

* 2021 Cancer Cell [Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer](https://pubmed.ncbi.nlm.nih.gov/34653365/)
